Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

CLLS

Cellectis S.A.

CIK 0001627281 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$3.17
↑ 0.08 (2.69%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BearishOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Risks: Ownership, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$227.67M
P/E Ratio
-3.37
EPS
-0.67
Dividend Yield
Not covered
52W Position
41%
Beta
1.86

Valuation multiples

Fwd P/E
Not covered
PEG
0.00
P/B
3.00
P/S
3.12
EV/Revenue
2.28
ROE
-89.1%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 41%
$1.57$5.48

Latest Financials

2025-12-31 FY
Revenue
$72.95M
Net Income
-$67.59M
Total Assets
$324.72M
Free Cash Flow
-$41.76M

Recent news